Honey Blankenship/LinkedIn
Aug 16, 2026, 13:53
Honey Blankenship: United by a Shared Commitment to the Bleeding Disorders Community
Honey Blankenship, Hemophilia Patient Navigator at Pfizer, shared on LinkedIn:
”Coming home from an incredible conference feeling especially grateful.
Grateful for the patients, healthcare providers, advocacy groups, and industry partners who came together with a shared commitment to making a difference for the bleeding disorders community.
Most of all, I’m grateful for the relationships and lifelong friendships that continue to grow through this work.
I feel incredibly fortunate to work for a company that gives me the opportunity to support patients and contribute to a community that inspires me every day.
Leaving with a full heart, new connections, and even more motivation for the work ahead.”
Stay updated with Hemostasis Today.
-
Aug 16, 2026, 14:37Christopher Hanson: Broad-Spectrum Platelet Inhibition via Non-Odorant OR2L13 Agonists
-
Aug 16, 2026, 14:27Preeti Verma: The Case of the Missing Clue – Why Databases Need a Clinician’s Eye
-
Aug 16, 2026, 14:22FDA Licenses First Freeze-Dried Plasma Product in the United States
-
Aug 16, 2026, 14:20Christopher Cannon: Discontinuation vs. Continuation of Statin Therapy in Adults Aged Under 75
-
Aug 16, 2026, 13:46Sagar Bejalwar: A Rare Bleeding Disorder and the Importance of Specialized Care
-
Aug 16, 2026, 13:39Sharun Khan: Advancing Regenerative Medicine Through Veterinary Translational Science
-
Aug 16, 2026, 13:21Francois Roubille: New ESC Consensus on Inflammation in Coronary Syndromes
-
Aug 16, 2026, 13:05Neil Morgan: Submit Your Abstract for BSHT 2027
-
Aug 16, 2026, 12:50Heba Youssef: Can Cefoperazone Cause Coagulopathy?